HK1026739A1 - Methods for detecting cell apoptosis - Google Patents
Methods for detecting cell apoptosisInfo
- Publication number
- HK1026739A1 HK1026739A1 HK00104835A HK00104835A HK1026739A1 HK 1026739 A1 HK1026739 A1 HK 1026739A1 HK 00104835 A HK00104835 A HK 00104835A HK 00104835 A HK00104835 A HK 00104835A HK 1026739 A1 HK1026739 A1 HK 1026739A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- apoptosis
- cell apoptosis
- detection
- detecting cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3096196P | 1996-11-15 | 1996-11-15 | |
US08/967,625 US6048703A (en) | 1996-11-15 | 1997-11-12 | Methods for detecting cell apoptosis |
PCT/US1997/020214 WO1998021590A1 (fr) | 1996-11-15 | 1997-11-13 | Procedes de detection de l'apoptose cellulaire |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1026739A1 true HK1026739A1 (en) | 2000-12-22 |
Family
ID=26706638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00104835A HK1026739A1 (en) | 1996-11-15 | 2000-08-02 | Methods for detecting cell apoptosis |
Country Status (9)
Country | Link |
---|---|
US (2) | US6048703A (fr) |
EP (1) | EP0975971B1 (fr) |
AT (1) | ATE320006T1 (fr) |
AU (1) | AU5169998A (fr) |
CA (1) | CA2270866A1 (fr) |
DE (1) | DE69735436T2 (fr) |
DK (1) | DK0975971T3 (fr) |
HK (1) | HK1026739A1 (fr) |
WO (1) | WO1998021590A1 (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6342611B1 (en) * | 1997-10-10 | 2002-01-29 | Cytovia, Inc. | Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof |
DE69937835T2 (de) * | 1998-09-24 | 2009-01-02 | Promega Corp., Madison | Antikörper für apoptosemarker und anwendungsverfahren |
EP1173486A1 (fr) * | 1999-04-15 | 2002-01-23 | Merck Frosst Canada & Co. | Anticorps reconnaissant l'app clivee par les caspases et leurs procedes d'utilisation |
US6482411B1 (en) * | 1999-08-27 | 2002-11-19 | Board Of Regents, The University Of Texas System | Methods of reducing bone loss with CD40 ligand |
ATE311595T1 (de) * | 2000-07-21 | 2005-12-15 | Evotec Ag | Verfahren zur detektion der apoptose durch ermittlung von cytochrom c als apoptosespezifischem marker, der durch zelluläre ausschüttungsvorgänge ins extrazelluläre medium abgegeben wird |
AU2002361642A1 (en) * | 2001-11-16 | 2003-06-10 | The University Of Tennessee Research Corporation | Recombinant antibody fusion proteins and methods for detection of apoptotic cells |
US7541150B2 (en) * | 2002-04-08 | 2009-06-02 | University Of Louisville Research Foundation, Inc | Method for the diagnosis and prognosis of malignant diseases |
US7357928B2 (en) * | 2002-04-08 | 2008-04-15 | University Of Louisville Research Foundation, Inc. | Method for the diagnosis and prognosis of malignant diseases |
JP2005530515A (ja) * | 2002-06-26 | 2005-10-13 | ユニヴァーシティー オヴ ルイスヴィル リサーチ ファウンデイション インコーポレイテッド | アポトーシスの検出方法 |
US8492107B2 (en) * | 2004-04-15 | 2013-07-23 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
ES2367311T3 (es) * | 2004-04-15 | 2011-11-02 | University Of Florida Research Foundation, Inc. | Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales. |
EP1745149A4 (fr) | 2004-04-15 | 2008-08-06 | Univ Florida | Neuro-proteines utilisees comme biomarqueurs pour deceler une lesion du systeme nerveux et d'autres troubles neurologiques |
EP2236153A3 (fr) | 2005-01-25 | 2012-08-22 | Five Prime Therapeutics, Inc. | Composés et méthodes pour le traitement de maladies cardiaques |
US8379197B2 (en) * | 2006-01-05 | 2013-02-19 | Chemimage Corporation | Spectroscopic systems and methods for classifying and pharmaceutically treating cells |
TWI429658B (zh) | 2006-06-07 | 2014-03-11 | Bioalliance Cv | 辨認癌症細胞上表現的cd43與cea之含碳水化合物抗原決定區的抗體及其使用方法 |
WO2008021211A2 (fr) * | 2006-08-10 | 2008-02-21 | Fred Hutchinson Cancer Research Center | Compositions et procédés de modulation de l'apoptose dans des cellules surexprimant les protéines membres de la famille bcl-2 |
AU2008338313B2 (en) | 2007-12-18 | 2014-01-16 | Bioalliance C.V. | Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same |
WO2009088837A2 (fr) * | 2007-12-31 | 2009-07-16 | The University Of Louisville Research Foundation, Inc. | Procédés et produits pour cibler, capturer et caractériser des cellules souches |
CA2733990C (fr) * | 2008-08-11 | 2018-12-11 | Banyan Biomarkers, Inc. | Procede de detection de biomarqueurs et test d'etat neurologique |
WO2011041731A2 (fr) | 2009-10-02 | 2011-04-07 | Fred Hutchinson Cancer Research Center | Procédé destiné à inhiber des protéines de survie apparentées aux bcl-2 |
WO2011041737A2 (fr) | 2009-10-02 | 2011-04-07 | Fred Hutchinson Cancer Research Center | Inhibiteurs de bcl-2 à gain de fonction |
WO2011062997A2 (fr) | 2009-11-17 | 2011-05-26 | Musc Foundation For Research Development | Anticorps monoclonaux humains pour nucléoline humaine |
EP2714094B1 (fr) | 2011-06-02 | 2016-02-24 | The University of Louisville Research Foundation, Inc. | Nanoparticules conjuguées à un agent antinucléoline |
WO2016179394A1 (fr) | 2015-05-05 | 2016-11-10 | Malik Mohammad Tariq | Nanoparticules conjuguées à un agent antinucléoline en tant que radiosensibiliseurs et agents de contraste d'imagerie par résonance magnétique (irm) et/ou en rayons x |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08511690A (ja) * | 1993-06-24 | 1996-12-10 | ザ・ジェネラル・ホスピタル・コーポレーション | プログラムされた細胞死遺伝子及びタンパク質 |
US5536639A (en) * | 1994-03-25 | 1996-07-16 | Cephalon, Inc. | Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products |
US5605826A (en) * | 1994-06-10 | 1997-02-25 | Panorama Research, Inc. | 24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis |
US6288037B1 (en) * | 1996-01-29 | 2001-09-11 | Basf Aktiengesellschaft | Substrates and inhibitors for cysteine protease ICH-1 |
-
1997
- 1997-11-12 US US08/967,625 patent/US6048703A/en not_active Expired - Lifetime
- 1997-11-13 DK DK97946547T patent/DK0975971T3/da active
- 1997-11-13 AT AT97946547T patent/ATE320006T1/de active
- 1997-11-13 EP EP97946547A patent/EP0975971B1/fr not_active Expired - Lifetime
- 1997-11-13 CA CA002270866A patent/CA2270866A1/fr not_active Abandoned
- 1997-11-13 DE DE69735436T patent/DE69735436T2/de not_active Expired - Lifetime
- 1997-11-13 AU AU51699/98A patent/AU5169998A/en not_active Abandoned
- 1997-11-13 WO PCT/US1997/020214 patent/WO1998021590A1/fr active IP Right Grant
-
1999
- 1999-12-29 US US09/473,619 patent/US7256252B1/en not_active Expired - Fee Related
-
2000
- 2000-08-02 HK HK00104835A patent/HK1026739A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0975971A4 (fr) | 2002-09-25 |
US7256252B1 (en) | 2007-08-14 |
DK0975971T3 (da) | 2006-07-03 |
EP0975971B1 (fr) | 2006-03-08 |
CA2270866A1 (fr) | 1998-05-22 |
AU5169998A (en) | 1998-06-03 |
EP0975971A1 (fr) | 2000-02-02 |
DE69735436D1 (de) | 2006-05-04 |
ATE320006T1 (de) | 2006-03-15 |
DE69735436T2 (de) | 2006-10-26 |
US6048703A (en) | 2000-04-11 |
WO1998021590A1 (fr) | 1998-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1026739A1 (en) | Methods for detecting cell apoptosis | |
PL331612A1 (en) | Method of determining condition of human body by measurement of peptides | |
PT991421E (pt) | Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa | |
HK1030018A1 (en) | Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor | |
NZ331866A (en) | Compounds for immunotherapy and immunodiagnosis of prostate cancer | |
NO973381L (no) | Diagnostisk testanordning med testområder bestående av flere sjikt, samt fremgangsmåte for bestemmelse av en analytt ved hjelp av denne | |
WO2000061808A3 (fr) | Procedes de detection d'acides nucleiques revelateurs de cancer | |
MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
AU4040097A (en) | Signal amplification method | |
CA2284817A1 (fr) | Procede permettant de determiner la presence d'une proteine brca issue de mutation | |
DE60137264D1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
ES2166822T3 (es) | Procedimientos de seleccion de la enfermedad de crohn usando alelos de microsatelites de tnf. | |
NZ338068A (en) | Diagnosis of early gastric cancer detecting cyclooxygenase-2 mRNA expression or Cox-2 protein overexpression | |
WO1999047925A3 (fr) | Procedes et compositions pour le diagnostic de la polyarthrite rhumatoide | |
DE69507470D1 (de) | Diagnose von krebs, dessen zellen das am tyrosin phosphorylierte crkl-protein exprimieren | |
WO1999028461A3 (fr) | Dispositif et procede d'induction de l'apoptose en faisant interferer des proteines de type bip | |
AU5143099A (en) | Protein fragment complementation assays for the detection of biological or drug interactions | |
FI973561A0 (fi) | Menetelmä ja yhdisteitä analysoitavien aineiden määrittämiseksi remanenssimittausten avulla ja mainittujen yhdisteiden käyttö | |
MXPA02000293A (es) | Isoformas de la amp ciclico fosfodiesterasa y metodos de uso. | |
DE69837808D1 (de) | pRb2/p130 PEPTIDINHIBITOREN DER cdk2 KINASEAKTIVITÄT | |
WO2001002828A3 (fr) | Diagnostic du cancer par detection de polynucleotides ou de polypeptides ash2 | |
AU3589101A (en) | Dpi-6, a putative therapeutic target and biomarker in neuropsychiatric and neurological disorders | |
WO2000012754A8 (fr) | Procede d'identification de substances pour le traitement de troubles induits par la c-jun | |
WO2001065262A3 (fr) | Reactifs et methodes de detection des pathologies mammaires | |
AU2518997A (en) | Analysis for the presence of degenerative brain disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20171112 |